TrialBMC medicine2025

The efficacy and safety of hydroxychloroquine in patients with chronic inflammatory cardiomyopathy: a multicenter randomized study (HYPIC trial).

Wu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.